IRIS UniCatt

Giampietro, Antonella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.820
NA - Nord America 2.721
AS - Asia 1.541
SA - Sud America 432
AF - Africa 45
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
AN - Antartide 1
Totale 7.571
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.656
DE - Germania 1.104
SG - Singapore 649
CN - Cina 492
SE - Svezia 409
BR - Brasile 386
IT - Italia 351
UA - Ucraina 180
FR - Francia 177
GB - Regno Unito 124
IE - Irlanda 120
ID - Indonesia 84
FI - Finlandia 83
IN - India 78
RU - Federazione Russa 74
PL - Polonia 68
VN - Vietnam 43
CA - Canada 38
BE - Belgio 25
HK - Hong Kong 25
NL - Olanda 25
AT - Austria 23
TR - Turchia 23
BD - Bangladesh 21
IQ - Iraq 19
KR - Corea 18
ES - Italia 17
JP - Giappone 17
IR - Iran 14
MX - Messico 13
AR - Argentina 12
ZA - Sudafrica 11
CI - Costa d'Avorio 9
VE - Venezuela 9
CO - Colombia 8
UZ - Uzbekistan 8
CZ - Repubblica Ceca 7
PK - Pakistan 7
PT - Portogallo 7
SA - Arabia Saudita 7
EG - Egitto 6
LK - Sri Lanka 6
AE - Emirati Arabi Uniti 5
EC - Ecuador 5
JM - Giamaica 5
MA - Marocco 5
PY - Paraguay 5
AL - Albania 4
AZ - Azerbaigian 4
JO - Giordania 4
BG - Bulgaria 3
CH - Svizzera 3
ET - Etiopia 3
EU - Europa 3
KE - Kenya 3
MD - Moldavia 3
PE - Perù 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
AU - Australia 2
BB - Barbados 2
BH - Bahrain 2
BY - Bielorussia 2
CR - Costa Rica 2
GH - Ghana 2
GR - Grecia 2
HN - Honduras 2
KG - Kirghizistan 2
KZ - Kazakistan 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
CL - Cile 1
DK - Danimarca 1
GE - Georgia 1
GU - Guam 1
HU - Ungheria 1
IL - Israele 1
KW - Kuwait 1
LB - Libano 1
LI - Liechtenstein 1
ML - Mali 1
NG - Nigeria 1
NO - Norvegia 1
PW - Palau 1
RS - Serbia 1
SC - Seychelles 1
TH - Thailandia 1
Totale 7.571
Salva come PNG Salva come JPEG
Città #
Chandler 582
Singapore 296
Ashburn 158
New York 123
Dublin 112
San Mateo 108
Beijing 94
Rome 91
Ann Arbor 82
Jakarta 81
Jacksonville 72
Munich 72
Fairfield 68
Wilmington 68
Marseille 61
Warsaw 58
Boston 57
Milan 57
Los Angeles 55
Nürnberg 55
Nanjing 48
Moscow 47
The Dalles 45
Bremen 44
Seattle 41
Cattolica 40
Princeton 40
Hefei 38
Frankfurt am Main 37
Dearborn 34
Houston 34
Helsinki 33
São Paulo 33
Redwood City 31
Woodbridge 29
Chicago 26
Brussels 24
Nanchang 24
Cambridge 23
Hong Kong 23
Shanghai 23
Hangzhou 21
Lawrence 21
Nuremberg 21
Boardman 20
London 20
Mountain View 20
Zhengzhou 19
Hyderabad 17
University Park 17
Turku 16
Hanoi 15
North Bergen 15
Seoul 15
Shenyang 15
Fremont 14
Montreal 14
Brooklyn 13
Guangzhou 13
Santa Clara 13
Augusta 12
Belo Horizonte 12
Düsseldorf 12
Norwalk 12
Rio de Janeiro 12
Vienna 12
Bexley 11
Ho Chi Minh City 11
Kunming 11
Lauterbourg 11
Leawood 11
Hebei 10
Izmir 10
Abidjan 9
Dallas 9
Kish 9
Mumbai 9
Portsmouth 9
Redmond 9
Changsha 8
Lancaster 8
Tashkent 8
Toronto 8
Baghdad 7
Brescia 7
Colombo 7
Piacenza 7
Porto Alegre 7
Pune 7
Tianjin 7
Washington 7
Andover 6
Canterbury 6
Jiaxing 6
Mexico City 6
Paris 6
Tokyo 6
West Jordan 6
Amsterdam 5
Asunción 5
Totale 3.727
Salva come PNG Salva come JPEG
Nome #
Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature review 251
Hypophysitis Outcome and Factors Predicting Responsiveness to Glucocorticoid Therapy: A Prospective and Double-Arm Study. 251
Double pituitary adenomas 206
Coenzyme Q10 evaluation in pituitary-adrenal axis disease: preliminary data. 174
Non Alcoholic Fatty Liver Disease is Associated with Increased GHBP and Reduced GH/IGF-I Levels 167
Typical and Atypical Pituitary Adenomas: A Single-Center Analysis of Outcome and Prognosis 166
Role of a mini-invasive approach in the diagnosis and treatment of tubo-peritoneal infertility as an altenative to IVF [Il ruolo di un approccio chirurgico mini-invasivo nella diagnosi e trattamento della sterilità tubo-peritoneale in alternativa alla FIVET] 165
Male fertility and reduction in semen parameters: A single tertiary-care center experience 164
Effects of gherlin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 158
Circulating endothelial cells as marker of endothelial damage in male hypogonadism 153
An Overview of Diagnosis of Primary Autoimmune Hypophysitis in a Single Prospective Monocentric Experience 152
NOVEL BIOMARKERS OF ANDROGEN DEFICIENCY FROM SEMINAL PLASMA PROFILING USING HIGH-RESOLUTION MASS SPECTROMETRY. 146
Treatment with octreotide LAR in clinically non-functioning pituitary adenoma: results from a case-control study 136
Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels 131
Circulating endothelial cells as marker of endothelial damage in male hypogonadism 129
Isolated growth hormone deficiency: clinical entity? 128
Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 124
Influence of diabetes mellitus on vertebral fractures in men with acromegaly 120
Radically resected pituitary adenomas: prognostic role of Ki67 labeling index in monocentric retrospective series and literature review 120
Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency 119
The Changing Clinical Spectrum of Hypophysitis 119
Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: An immunohistochemical study 115
Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomes 111
Pegvisomant and Pasireotide LAR as second line therapy in acromegaly: clinical effectiveness and predictors of response 111
The effect of treatment with growth hormone on fertility outcome in eugonadal women with growth hormone deficiency: report of four cases and review of the literature 110
Significant GH-deficiency after long-term cure by surgery in adult patients with Cushing s disease 110
Fertility and hypopituitarism 105
Pasireotide and Pegvisomant Combination Treatment in Acromegaly Resistant to Second Line Therapies: A Longitudinal Study 103
GH receptor isoforms and skeletal fragility in acromegaly 98
Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study. 96
DIAGNOSIS OF ENDOCRINE DISEASE: Primary Empty Sella: a comprehensive review 96
Synchronous Bilateral Adrenalectomy in ACTH-dependent Hypercortisolism: Predictors, Biomarkers and Outcomes 89
Characteristics and outcomes of Italian patients from the observational, multicentre, hypopituitary control and complications study (HypoCCS) according to tertiles of growth hormone peak concentration following stimulation testing at study entry 86
Reappraising the Role of Trans-Sphenoidal Surgery in Prolactin-Secreting Pituitary Tumors. 83
Human leucocyte antigens coeliac haplotypes and primary autoimmune hypophysitis in caucasian patients 81
The changing clinical spectrum of endocrine adverse events in cancer immunotherapy 81
Quantitative Analysis of the Seminal Plasma Proteome in Secondary Hypogonadism 80
Galectin-3 and Estrogen Receptor Alpha as Prognostic Markers in Prolactinoma: Preliminary Results From a Pilot Study 80
Pancreatic neuroendocrine tumors in MEN1 disease: a mono-centric longitudinal and prognostic study 79
Vertebral fractures in patients with acromegaly: a 3-year prospective study 78
Empty sella syndrome: Multiple endocrine disorders. 78
Effects of Pegvisomant and Pasireotide LAR on Vertebral Fractures in Acromegaly Resistant to First-generation SRLs. 77
Clinical management of teratoma, a rare hypothalamic-pituitary neoplasia 75
Neuro-radiological features can predict hypopituitarism in primary autoimmune hypophysitis 75
The Role of Growth Hormone Receptor Isoforms and Their Effects in Bone Metabolism and Skeletal Fragility 73
Glucose metabolism outcomes in acromegaly patients on treatment with pasireotide-LAR or pasireotide-LAR plus Pegvisomant 73
First Case of Mature Teratoma and Yolk Sac Testis Tumor Associated to Inherited MEN-1 Syndrome. 72
Autoantibody reactivity profile of primary autoimmune hypophysitis patients: preliminary results 72
Understanding the effect of acromegaly on the human skeleton. 71
Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly. 70
Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours 69
Growth hormone receptor isoforms and fracture risk in adult-onset growth hormone-deficient patients. 67
Hypothalamitis and pituitary atrophy 66
Pituitary Enlargement and Hypopituitarism in Patients Treated with Immune Checkpoint Inhibitors: Two Sides of the Same Coin? 65
The Pathogenic RET Val804Met Variant in Acromegaly: A New Clinical Phenotype? 65
Pancreas as an Unusual Metastatic Site of Medullary Thyroid Carcinoma: A Case of Very Long-term Follow-up Under Prolonged Treatment with Somatostatin Analogues 62
Short- and long-term responsiveness to low dose growth hormone (GH) in adult GH deficiency: Role of GH receptor polymorphism. 62
Multidimensional geriatric evaluation in acromegaly: a comparative cross-sectional study 62
Solitary Metastatic Melanoma of the Pituitary Gland: Report of Two Cases and Literature Review 61
Aggressive PitNETs and Potential Target Therapies: A Systematic Review of Molecular and Genetic Pathways 58
Acromegaly can be cured by first-line pasireotide treatment? 58
Acromegaly in the elderly patients 57
Prevalence of morphometric vertebral fractures in "difficult" patients with acromegaly with different biochemical outcomes after multimodal treatment. 56
Unveiling the Etiopathogenic Spectrum of Hypophysitis: A Narrative Review 53
Treatment of Acromegalic Osteopathy in Real-life Clinical Practice: The BAAC (Bone Active Drugs in Acromegaly) Study 53
Systemic comorbidities of acromegaly in real-life experience: which difference among young and elderly patients? 49
Bone safety of dual-release hydrocortisone in patients with hypopituitarism. 47
Multidisciplinary management of difficult/aggressive growth-hormone pituitary neuro-endocrine tumors 44
CD68+ and CD8+ immune cells are associated with the growth pattern of somatotroph tumors and response to first generation somatostatin analogs 44
Colon Cancer Presenting as Pituitary Mass and Hypopituitarism: Recognition and Multidisciplinary Approach of a Rare Case 42
The multi-biomarker acro-TIME score predicts fg-SRLs response: preliminary results of a retrospective acromegaly cohort 40
Trouillas's Grading and Post-Surgical Tumor Residue Assessment in Pituitary Adenomas: The Importance of the Multidisciplinary Approach 40
De-escalation treatment with pasireotide for acromegaly: a long-term experience 39
Trouillas’s Grading and Post-Surgical Tumor Residue Assessment in Pituitary Adenomas: The Importance of the Multidisciplinary Approach 36
Second line treatment of acromegaly: Pasireotide or Pegvisomant? 32
Psychological complications in patients with acromegaly: relationships with sex, arthropathy, and quality of life 32
Cholecalciferol Use Is Associated With a Decreased Risk of Incident Morphometric Vertebral Fractures in Acromegaly 32
Markers of humoral and cell-mediated immune response in primary autoimmune hypophysitis: a pilot study 30
Bone health and skeletal fragility in second- and third-line medical therapies for acromegaly: preliminary results from a pilot single center experience 29
IGF-I levels during standard Lanreotide dose predicts biochemical outcome of high-frequency regimen in acromegaly 29
Effects of glucocorticoid replacement therapy in patients with pituitary disease: A new perspective for personalized replacement therapy 29
Genes of the “regulation of lymphocyte activation” pathway may influence immune cells infiltration in growth hormone secreting pituitary tumors 28
Cancer screening in patients with acromegaly: a plea for a personalized approach and international registries 28
Pregnancy in Autoimmune Hypophysitis: Management of a Rare Condition 28
Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours 26
Empty sella syndrome: an update 25
Factors associated with disease control failure in acromegaly patients treated with pegvisomant: an ACROSTUDY analysis 24
Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience 23
The Differential Diagnosis between Pseudo Cushing's Syndrome and True Cushing's Syndrome in a Septic Patient in the Pre-Agonal Phase: A Case Report 23
Use of 111In-pentetreotide scintigraphy for diagnosis and management of resistant macroprolactinoma 23
Tumor features in adult papillary and adamantinomatous craniopharyngioma: neuroradiological evaluation of pituitary-hypothalamic-axis dysfunction and outcome prediction 20
Pegvisomant and Pasireotide LAR as second line therapy in acromegaly: clinical effectiveness and predictors of response 20
GH receptor polymorphisms guide second-line therapies to prevent acromegaly skeletal fragility: preliminary results of a pilot study 19
Partial response to first generation SSA guides the choice and predict the outcome of second line therapy in acromegaly 19
Cytokines and chemokines modulate the growth of pituitary adenoma/neuroendocrine tumors: preliminary results of a monocenter prospective pilot study 18
Clinical implications of the 2022 WHO classification on the multidisciplinary management of PitNETS patients 16
Vitamin D in pituitary driven osteopathies 14
A Toluene-induced Infundibulo-neuro-hypophysitis: Presentation of a New Cause of Hypophysitis Secondary to Toxic Exposure and Review on Toluene Inhalation Endocrine Effects 11
Long-term pasireotide-LAR treatment in the personalized therapy of patients with complex acromegaly: a collection of clinical experiences 11
Tumor features in adult papillary and adamantinomatous craniopharyngioma: neuroradiological evaluation of pituitary-hypothalamic-axis dysfunction and outcome prediction 6
Totale 7.697
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.166
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.166
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021399 0 42 11 42 50 27 47 9 43 55 68 5
2021/2022617 30 33 7 47 74 27 10 112 28 26 85 138
2022/20231.516 173 207 123 252 80 211 89 127 157 13 53 31
2023/2024717 32 160 17 32 31 142 35 8 28 34 93 105
2024/20251.843 30 40 124 75 101 74 37 67 273 188 395 439
2025/2026761 736 25 0 0 0 0 0 0 0 0 0 0
Totale 7.697